Sex-related differences in hemostasis and thrombosis

Journal of Gender-Specific Medicine

Volumn 4, Issue 2, 2001, Pages 59-64

  Seremetis, S V ^a  

^a MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; ESTROGEN DERIVATIVE; MESTRANOL; NORETYNODREL; ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; AUTOSOMAL INHERITANCE; BLOOD CLOTTING DISORDER; CHILDBIRTH; CONTRACEPTION; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; EMBOLISM; FEMALE; HEMOPHILIA; HEMOSTASIS; HUMAN; INCIDENCE; MALE; MENSTRUATION; POSTMENOPAUSE; PREGNANCY; RISK; SCREENING TEST; SEX DIFFERENCE; SEX LINKAGE; STRESS; THROMBOSIS; UTERUS BLEEDING; VON WILLEBRAND DISEASE;

CONTRACEPTIVES, ORAL, HORMONAL; DEAMINO ARGININE VASOPRESSIN; ESTROGEN REPLACEMENT THERAPY; FEMALE; HEMOPHILIA A; HEMOSTASIS; HUMANS; INFUSIONS, PARENTERAL; MALE; RISK FACTORS; SEX FACTORS; THROMBOSIS; VENOUS THROMBOSIS; VON WILLEBRAND DISEASE; X CHROMOSOME;

EID: 0035663803     PISSN: 15237036     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Females with von Willebrand disease: 72 years as the silent majority
2. Women with bleeding disorders
3. Diagnosis of von Willebrand disease
4. Factor XI deficiency and its management
5. Morphology of haemostasis in menstrual endometrium
6. Hemostasis in menstrual endometrium: A review
7. Menstruation in intraocular endometrial transplants in the rhesus monkey
8. Histological studies on the menstruating mucous membrane of the human uterus
9. Treatment of congenital coagulopathies
10. Human recombinant DNA-derived antihaemophilic factor (factor VIII) in the treatment of haemophilia A: Conclusions of a 5-year study of home therapy
11. Von Willebrand disease: Recognition and management
12. Frequency of inherited bleeding disorders in women with menorrhagia
13. Treatment of menorrhagia during menstruation: Randomised controlled trial of ethamsylate, mefenamic acid, and tranexamic acid
14. A prospective study of the incidence of deep-vein thrombosis within a defined urban population
15. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism: The Worcester DVT Study
16. The natural history and epidemiology of venous thrombosis
17. Phlogose und Thrombose
18. Identification of the same factor V mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C
19. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis
20. Inherited thrombophilia: Pathogenesis, clinical syndrome, and management
21. Risk factors for venous thrombosis: Prevalence, risk, and interaction
22. Prevalence of antithrombin deficiency in the healthy population
23. Prevalence of protein C deficiency in the healthy population
24. High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives
25. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis
26. Pulmonary embolism
27. Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation
28. Thrombotic risk of women with hereditary antithrombin III-, protein C-, and protein S-deficiency taking oral contraceptive medication
29. Oral contraceptive estrogen dose and the risk of deep venous thromboembolic disease
30. Risk of hospital admission for idiopathic venous thromboembolism among users of post-menopausal estrogens
31. Risk of venous thromboembolism in users of hormone replacement therapy
32. Oral contraceptives and thrombosis
33. Prospective study of exogenous hormones and risk of pulmonary embolism in women
34. Factor V Leiden mutation and the risks for thromboembolic disease: A clinical perspective